Across TCGA pan-cancer cohorts, RNU5B-2P RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RNU5B-2P data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU5B-2P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RNU5B-2P expression acts as an unfavorable survival marker, although some lineages such as BLCA and PAAD show a favorable association.
BLCA, KIRC, and PAAD are the cancer types where RNU5B-2P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.